Holen Sie sich die Stockscreener-App
8.8626
0.90%
-0.0474
Schlusskurs vom Vortag:
$8.91
Offen:
$8.89
24-Stunden-Volumen:
106.60K
Relative Volume:
0.02
Marktkapitalisierung:
$1.53B
Einnahmen:
$1.84M
Nettoeinkommen (Verlust:
$-118.44M
KGV:
-10.69
EPS:
-0.8291
Netto-Cashflow:
$-98.51M
1W Leistung:
+0.34%
1M Leistung:
-1.12%
6M Leistung:
+251.79%
1J Leistung:
+247.64%
1-Tages-Spanne:
$8.81
$8.96
1-Wochen-Bereich:
$8.55
$9.10
52-Wochen-Spanne:
$2.24
$12.05
Absci Corp Stock (ABSI) Company Profile
Firmenname
Absci Corp
Sektor
Branche
Telefon
(360) 949-1041
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
8.90 | 1.53B | 1.84M | -118.44M | -98.51M | -0.8291 |
VRTX
Vertex Pharmaceuticals Inc
|
525.08 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
804.12 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,000.43 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
139.74 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.10 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-01-22 | Eingeleitet | Needham | Buy |
| 2024-10-02 | Eingeleitet | Guggenheim | Buy |
| 2024-07-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Eingeleitet | Truist | Buy |
| 2022-03-02 | Fortgesetzt | Cowen | Market Perform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-11-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | BofA Securities | Neutral |
| 2021-08-16 | Eingeleitet | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-16 | Eingeleitet | Stifel | Hold |
Alle ansehen
Absci Corp Aktie (ABSI) Neueste Nachrichten
BTIG Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $16 - Moomoo
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - Stocktwits
Absci Corporation Stock (ABSI) Opinions on Investor Conference Participation - quiverquant.com
Bank of New York Mellon Corp Buys Shares of 386,832 Absci Corporation $ABSI - MarketBeat
ABSI: Absci Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Absci Corporation $ABSI Shares Bought by Bank of America Corp DE - MarketBeat
Absci Corp (ABSI) Valuation: PE, PB & Fair Value Analysis - tradingkey.com
Absci (NASDAQ:ABSI) Stock Price Down 4.8%Should You Sell? - MarketBeat
Can Absci’s (ABSI) Low-Frequency Hair Loss Therapy Redefine Its Long-Term Platform Potential? - simplywall.st
Absci Corp CFO Zachariah Jonasson Reports RSU Tax Withholding Share Transaction - kalkinemedia.com
Deutsche Bank AG Acquires New Stake in Absci Corporation $ABSI - MarketBeat
Artia Global Partners LP Acquires Shares of 464,444 Absci Corporation $ABSI - marketbeat.com
Absci (NASDAQ:ABSI) Trading 8.5% HigherWhat's Next? - MarketBeat
Certain Common Stock of Absci Corporation are subject to a Lock-Up Agreement Ending on 24-AUG-2026. - marketscreener.com
Absci (NASDAQ:ABSI) Shares Gap UpShould You Buy? - MarketBeat
Morgan Stanley Maintains Absci Corp(ABSI.US) With Hold Rating, Raises Target Price to $10 - 富途牛牛
Absci (ABSI) Q2 2026 Earnings Call Transcript - AOL.com
Ransi Mudalinayake Somaratne Net Worth (2026) - GuruFocus
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Zacks Investment Research
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma - The Globe and Mail
ABSI Looks 1092.2% Overvalued on GF Value™ - GuruFocus
Absci Corp (ABSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Absci (NASDAQ:ABSI) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Absci (NASDAQ:ABSI) Trading Down 4.4%Here's Why - MarketBeat
Will Absci (NASDAQ:ABSI) Spend Its Cash Wisely? - Moomoo
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Absci Corp. Earnings Call Highlights ABS-201 And Cash - The Globe and Mail
A Quick Look at Today's Ratings for Absci Corp(ABSI.US), With a Forecast Between $11 to $16 - Moomoo
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation - Yahoo Finance
Absci (ABSI) Could Be 32% Undervalued Following ABS 201 Data And Earnings - simplywall.st
Absci (NASDAQ:ABSI) Shares Gap Down After Earnings Miss - marketbeat.com
Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
BTIG Research Reiterates Buy Rating for Absci (NASDAQ:ABSI) - MarketBeat
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed? - Yahoo Finance
TD Cowen Maintains Absci Corp(ABSI.US) With Buy Rating - Moomoo
ABSI SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Absci Q2 2026 Earnings Call Transcript - MarketBeat
Absci Q2 Loss Narrows, Revenue Declines - Moomoo
Why is Absci stock tumbling today? - Investing.com
ABSI Looks 934.1% Overvalued on GF Value™ - GuruFocus
Absci Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Absci misses Q2 2026 estimates as stock falls after hours - Investing.com Nigeria
Absci (NASDAQ:ABSI) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Why is Absci stock tumbling today? By Investing.com - Investing.com Nigeria
Absci Q2 Earnings Call Highlights - MarketBeat
Absci earnings missed by $0.02, revenue fell short of estimates - Investing.com
Absci Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Absci shares tumble on earnings miss, weak revenue - Investing.com
Finanzdaten der Absci Corp-Aktie (ABSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Absci Corp-Aktie (ABSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pangalos Menelas N | Director |
May 13 '26 |
Buy |
5.36 |
37,453 |
200,748 |
232,308 |
| Busch Andreas | Chief Innovation Officer |
Mar 12 '26 |
Buy |
2.29 |
100,000 |
229,000 |
421,446 |
| Pangalos Menelas N | Director |
Feb 27 '26 |
Buy |
2.74 |
75,095 |
205,760 |
189,055 |
| McClain Sean | Chief Executive Officer |
Feb 23 '26 |
Option Exercise |
1.21 |
396,399 |
479,643 |
8,730,966 |
| McClain Sean | Chief Executive Officer |
Feb 02 '26 |
Sale |
2.99 |
26,761 |
80,015 |
8,334,567 |
| Jonasson Zachariah | CFO / CBO |
Feb 02 '26 |
Sale |
2.99 |
17,496 |
52,313 |
383,538 |
| VAN HOUTEN FRANS | Director |
Dec 05 '25 |
Buy |
3.72 |
40,000 |
148,800 |
63,320 |
| Pangalos Menelas N | Director |
Sep 22 '25 |
Buy |
2.66 |
95,785 |
254,788 |
113,960 |
| Bedrick Todd | SVP, CAO |
Sep 22 '25 |
Buy |
2.70 |
10,000 |
27,000 |
180,428 |
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):